In any situation where intravenous access is difficult to obtain in emergent, urgent, or medically necessary cases, the Arrow® EZ-IO® Intraosseous Vascular Access System from Teleflex is a proven,1 fast,2* and effective3 solution.
Emergencias, Teleflex
Arrow ® EZIO® Intraosseus Vascular Access System
In any situation where intravenous access is difficult to obtain in emergent, urgent, or medically necessary cases, the Arrow® EZ-IO® Intraosseous Vascular Access System from Teleflex is a proven,1 fast,2* and effective3 solution.
Related products
-
Control-Cric™ Emergency Cricothyrotomy
Read moreA surgical approach to a cricothyrotomy that helps to maintain control during a high-stress situation. This quick and controlled cricothyrotomy has been created to perform a blind cricothyrotomy in under 2 minutes, and is packaged to simplify the procedure.
-
LMA® Gastro™
Read moreThe LMA® Gastro™ Airway with Cuff Pilot™ Technology from Teleflex is the first laryngeal mask specifically designed to enable clinicians to proactively manage their patients’ airways while facilitating direct endoscopic access via the integrated endoscope channel. With the airway in place, clinicians can monitor end-tidal CO2 for patient safety.
-
LMA® Fastrack™
Read moreThe ‘can’t intubate – can’t ventilate’ situation is among the most feared and respected challenges in airway management. Designed for the anticipated or unanticipated difficult airway situation and for cardiopulmonary resuscitation, LMA Fastrach™ facilitates continuous ventilation and intubation.
-
Cartridge Details (Lactate, Haematology, Chemistries Electrolytes)
Read moreTo perform a test with i-STAT single-use cartridges, 2 to 3 drops of blood are applied to a cartridge, which is then inserted into an i-STAT 1 or i-STAT Alinity blood analyser. Results are available in approximately 2 minutes for most tests. The i-STAT System allows clinicians to stay with the patient to perform diagnostic testing to help accelerate clinical decisions and time to treatment.
Reviews
There are no reviews yet.